However, the results from the MDMX KD prostate cancer cells not only validated the importance of MDMX for InuA-induced MDM2 degradation, but also implied the existence of other molecular mechanisms, such as inhibition of MDM2 transcription, that contribute to InuA’s inhibitory effects on MDM2. This evidence concerns the gene MDM2 and prostate carcinoma.